Form 4: Precision Biosciences Director Buys Shares
Insider Transaction (Form 4)
Melinda Brown, a Director of Precision Biosciences Inc, purchased 1,135 shares of common stock on September 25, 2026 for $6.27 per share.
Summary
- Open-market purchase: acquired 1,135 Common Stock at $6.27 ($7,116) on September 25, 2026; holds 45,481 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $7,116, committing personal capital to the stock.
Insider Transactions
Melinda Brown — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-25 | Open-market purchase | Common Stock | 1,135 | $6 | $7.1K | 45,481 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-25 | Open-market purchase (1,135 shares) |
Keywords
insider transaction, Form 4, DTIL, PRECISION BIOSCIENCES INC, bullish, Melinda Brown
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.